Thus, further studies will be needed to elucidate the mechanism underlying the elevated ALT levels observed in patients with NAFLD and mutant ADH1B/ALDH2 alleles. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.